Log in to your Inderes Free account to see all free content on this page.

Redwood Pharma

Less than 1K followers

All

Press releases

3rd party

ShowingAll content types

Regulatory press release7/28/2024, 12:30 PM

Redwood Pharma files for bankruptcy

Regulatory press release6/26/2024, 9:00 AM

Redwood Pharma provides a new update regarding divestment of company assets

Press release6/12/2024, 10:00 AM

Redwood Pharma provides an update on the process for divesting the company's assets

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release5/23/2024, 11:00 AM

Redwood Pharma provides an update on the company's future

Press release5/8/2024, 6:30 AM

Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle

Press release5/7/2024, 6:30 AM

Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements

Press release5/6/2024, 1:00 PM

Redwood Pharma's board subscribes to units in the ongoing new issue

Press release2/28/2024, 7:30 AM

Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle

Press release12/20/2023, 8:10 AM

Redwood Pharma's CEO Martin Vidaeus in year-end interview

Press release12/19/2023, 7:00 AM

Redwood Pharma to participate in the JP Morgan Healthcare Conference

Regulatory press release11/30/2023, 7:30 AM

Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

Press release11/22/2023, 7:30 AM

Redwood Pharma to participate in the NLS Days partner conference in Copenhagen

Press release10/19/2023, 9:15 AM

Redwood Pharma to participate in the BIO-Europe partnering conference in Munich

Regulatory press release5/31/2023, 9:10 PM

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

Press release3/17/2023, 12:00 PM

Redwood Pharma completes recruitment for clinical trial with RP501 for dry eye

Press release1/24/2023, 7:30 AM

Redwood Pharma takes important steps towards the commercial production of its dry eye product

Regulatory press release12/15/2022, 4:00 PM

Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501

Press release10/19/2022, 1:18 PM

Interview with CEO Martin Vidaeus of Redwood Pharma at BioStock Investor Meeting, Stockholm

Press release10/14/2022, 6:30 AM

Redwood Pharma: Streamed video of CEO Martin Vidaeus presenting at Aktieportföljen Live in Stockholm, Sweden on Oct. 11, 2022

Press release10/3/2022, 1:42 PM

Redwood Pharma to present at AKTIEPORTFÖLJEN LIVE SVERIGE in Stockholm on 11[th] of Oct. 2022 at 14:45

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.